FTD Underdiagnosed: Hispanic Populations Face Diagnostic Hurdles

Frontotemporal dementia (FTD), a progressive brain disease impacting behavior, movement, and speech, commonly affects individuals between 45 and 64 years old. Unlike Alzheimer's disease, FTD primarily damages the frontal and temporal lobes, leading to symptoms such as apathy, inappropriate social behavior, and loss of empathy.

Recent research suggests that Hispanic populations, historically underrepresented in FTD studies, may experience more pronounced symptoms and higher cognitive impairment upon diagnosis. These individuals often encounter diagnostic delays averaging four years from the initial onset of symptoms. Such delays are attributed to educational disparities affecting healthcare access and potential misattribution of symptoms to psychiatric conditions.

The study found that Hispanic patients were more likely to exhibit motor symptoms, while non-Hispanic white patients tended to show more behavioral changes. Despite these differences, neuropsychological results were similar between the groups. Barriers to timely diagnosis include late presentation to specialty care, limited access to specialists, and cultural or linguistic factors influencing help-seeking behaviors.

Researchers aim to build larger cohorts to better understand these observed differences, whether they stem from FTD subtypes, referral patterns, or diagnostic delays. The ultimate goal is to improve the early recognition and diagnosis of FTD in all populations.